4//SEC Filing
Izzar Rachid 4
Accession 0001127602-24-004794
CIK 0000875045other
Filed
Feb 12, 7:00 PM ET
Accepted
Feb 13, 6:00 PM ET
Size
8.3 KB
Accession
0001127602-24-004794
Insider Transaction Report
Form 4
BIOGEN INC.BIIB
Izzar Rachid
Head of Global Product Strat.
Transactions
- Exercise/Conversion
Common Stock
2024-02-09+1,515→ 9,081 total - Tax Payment
Common Stock
2024-02-09$240.98/sh−445$107,236→ 8,636 total - Exercise/Conversion
Restricted Stock Unit
2024-02-09−1,515→ 1,515 totalExercise: $0.00Exp: 2025-02-10→ Common Stock (1,515 underlying)
Footnotes (1)
- [F1]The restricted stock units vest in three equal yearly installments beginning on the first anniversary of the grant date of February 10, 2022.
Documents
Issuer
BIOGEN INC.
CIK 0000875045
Entity typeother
Related Parties
1- filerCIK 0001875506
Filing Metadata
- Form type
- 4
- Filed
- Feb 12, 7:00 PM ET
- Accepted
- Feb 13, 6:00 PM ET
- Size
- 8.3 KB